Here are the top 5 articles for the month of December.
Hi, I'm Jaime Rosenberg for The American Journal of Managed Care®. Here are the top 5 articles for the month of December.
Number 5: Competing breast cancer tests vied for attention from clinicians and payers at the San Antonio Breast Cancer Symposium.
Number 4: While the Oncology Care Model is likely not a sustainable model for oncology care, it will probably inform what structure comes next, according to Michael Kolodziej, MD, vice president and chief innovation officer, ADVI Health.
Number 3: A new study is adding to the debate of statin use to prevent cardiovascular disease, arguing that the benefits don't outweigh the harms.
Number 2: A federal judge in Texas ruled that the Affordable Care Act's individual mandata is unconstitutional and that the rest of the law must also fall.
Number 1: New reports from the CDC highlight troubling increasing trends in suicides and drug overdose rates as life expectancy in the United States declined for the second year in a row.
To read all of these articles and more, visit AJMC.com.
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Research Shows Prior Authorization Denials Delay Critical Immunology Care
May 10th 2024Results featured at the Academy of Managed Care Pharmacy 2024 annual meeting revealed a pattern of prior authorization rejections that could delay necessary therapeutic treatments for various patient groups.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Patients With Advanced, Recurrent Melanoma May Experience Lasting AEs From ICM Therapy
May 9th 2024A cross-sectional, mixed-methods study found that adverse effects (AEs) can occur even after 1 year of treatment with immune checkpoint modulator (ICM) therapy in patients with melanoma.
Read More